![Dalton Smart](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dalton Smart
Algemeen Directeur bij
HARPOON THERAPEUTICS, INC.
Vermogen: 1 M $ op 31-05-2026
Profiel
Mr. Dalton E.
Smart is a Senior Vice President-Finance & Global Controller at Merck & Co., Inc., a Chief Executive Office & Director at Afferent Pharmaceuticals, Inc., a Chief Executive Officer at Calporta Therapeutics, Inc., a Chief Executive Officer at Harpoon Therapeutics, Inc., a Chief Executive Officer & Director at Imago BioSciences, Inc., a Chief Executive Officer & Director at Prometheus Biosciences, Inc., a President & Director at Acceleron Pharma, Inc., a President & Director at ArQule, Inc., a President & Director at Caraway Therapeutics, Inc. and a President, Director & Vice President-Tax at Tilos Therapeutics, Inc. He is on the Board of Directors at Terns Pharmaceuticals, Inc., Junior Achievement of New Jersey, Inc., Afferent Pharmaceuticals, Inc., Imago BioSciences, Inc., Prometheus Biosciences, Inc., Acceleron Pharma, Inc., ArQule, Inc., Caraway Therapeutics, Inc. and Tilos Therapeutics, Inc.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 05-05-2026 | 9.388 ( 0% ) | 1 M $ | 31-05-2026 |
Actieve functies van Dalton Smart
| Bedrijven | Functie | Begin |
|---|---|---|
| MERCK & CO., INC. | Comptroller/Controller/Auditor | 04-12-2023 |
| HARPOON THERAPEUTICS, INC. | Algemeen Directeur | - |
| ACCELERON PHARMA INC. | President | - |
| ARQULE, INC. | President | - |
| TERNS PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 05-05-2026 |
| PROMETHEUS BIOSCIENCES, INC. | Algemeen Directeur | - |
| IMAGO BIOSCIENCES, INC. | Algemeen Directeur | - |
Junior Achievement of New Jersey, Inc.
 Junior Achievement of New Jersey, Inc. Part of JA Worldwide, Inc., Junior Achievement of New Jersey, Inc. is a company based in Princeton, NJ. James W. Horne has been the CEO of the company since 2022. | Directeur/Bestuurslid | - |
Caraway Therapeutics, Inc.
 Caraway Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company for the treatment of genetically defined neurodegenerative and rare diseases | President | - |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
68
Eerstegraads connecties
12
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Afferent Pharmaceuticals, Inc.
 Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, selective drugs for the treatment of a range of debilitating neurogenic disorders | Health Technology |
Junior Achievement of New Jersey, Inc.
Junior Achievement of New Jersey, Inc. Part of JA Worldwide, Inc., Junior Achievement of New Jersey, Inc. is a company based in Princeton, NJ. James W. Horne has been the CEO of the company since 2022. | |
Imago BioSciences, Inc.
 Imago BioSciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicines for the treatment of myeloproliferative neoplasms and bone marrow diseases | Health Technology |
Calporta Therapeutics, Inc.
 Calporta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule agonists | Health Technology |
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases | Health Technology |
Tilos Therapeutics, Inc.
 Tilos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for cancer, fibrosis and autoimmune disease | Health Technology |
Prometheus Biosciences, Inc.
 Prometheus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops medicines for immune-mediated diseases | Health Technology |
Terns Pharmaceuticals, Inc.
 Terns Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small-molecule product candidates to address serious diseases including oncology and obesity | Health Technology |
Caraway Therapeutics, Inc.
Caraway Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company for the treatment of genetically defined neurodegenerative and rare diseases | Health Technology |
